Equatorial Healthcare Services is Ghanaian, American oriented Pharmaceutical /Chemical and Cosmetic company formed in 1997 by a group of pharmaceutical scientists trained both in Ghana and the United States. The company’s president, Dr Kwasi A. Ohemeng, received his first degree in pharmacy from Ghana and a Ph. D in pharmaceutical sciences from Duquesne University, Pittsburgh, Pa and Post-doctoral training at the University of North Carolina, Chapel Hill. He has over 25 years experience working with several major drug manufacturing companies in the United States, rising to the position of Executive Director of Medicinal Chemistry at Paratek Pharmaceuticals, Boston Ma. He has participated in various U.S and International conferences in the industry and has a great deal of familiarity with the various aspects of the drug development/manufacturing business including current research and development activities. He has up-to-date information on current research and development activities with more than thirty patents and eighty five publications and presentations to his credit.
EHS is involved in the manufacturing and distribution of healthcare products of relevance to the tropical world. Equatorial Healthcare services initial operations are mainly in Ghana but its long term objective is to target the entire West African regional market.
The company has a strong believe that there are several health related problems in the tropics which would best be solved only by the local Scientists. This until recently has not been possible for several reason but particularly lack of Scientist in the field.
Since malaria is a primary cause for morbidity in most sub-Saharan African countries, the company’s initial focus is the production of drugs that would address both the preventive and curative aspects of this disease including;
Repelling the mosquitoes from biting the human target.
Elimination of the mosquitoes from living and sleeping areas.
Treatment of the disease - malaria and associated symptoms.
Equatorial also focuses on agricultural problems of crops and animals that are of relevance to the tropical World – Palm, Cocoa, Coffee Poultry and Livestock.
Current researches in our laboratories are directed toward the development of natural product derived treatment of typhoid fever which is so endemic in Ghana and the tropical world. Part of our research efforts also directed towards finding herbal drugs for the treatment of prostrate cancer.
Equatorial intends to be a market leader in Ghana and the West African Sub-region We are currently seeking marketing opportunities, in neighboring countries, and countries in the tropical world.
Our main focus has been to produce drugs locally, that are efficacious, safe and of high quality. The Q in Equatorial stands for product quality and we believe in the quality of product. Our commitment to our customer is what directs our research and development efforts.
Equatorial Healthcare Services Company Ltd, (EHS) positions itself as an innovative scientific company that researches into the production of drugs and formulations that satisfy the local market’s unmet Health needs.
Since malaria is a primary cause for morbidity in most Sub-Saharan African countries, the company has a major emphasis in the supply of products, that address both the preventive and curative aspects of the disease:
Repelling mosquitoes from biting the human target: Equatorial Body Guard®
Elimination of mosquitoes from living and sleeping areas: Equatorial Insect Blaster®
Treatment of the disease - malaria and associated symptoms: Equimol®, Equitrim® & Equimesin®
The company’s initial operations are mainly in Ghana, but its long -term objective is to target the entire West African regional market. It intends to be a market leader in the West African Sub-Saharan region. Equatorial is currently seeking marketing opportunities in neighboring and other countries in the tropical world.
Stands For: -
– HIGH QUALITY